TY - JOUR AU - Bisceglie, A. M. AU - Lyra, A. C. AU - Schwartz, M. AU - Reddy, R. K. AU - Martin, P. AU - Gores, G. PY - 2003 DA - 2003// TI - Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status JO - Am J Gastroenterol VL - 98 ID - Bisceglie2003 ER - TY - JOUR PY - 1999 DA - 1999// TI - C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium JO - J Viral Hepat VL - 6 UR - https://doi.org/10.1046/j.1365-2893.1999.6120139.x DO - 10.1046/j.1365-2893.1999.6120139.x ID - ref2 ER - TY - JOUR AU - El-Serag, H. B. AU - Mason, A. C. PY - 1999 DA - 1999// TI - Rising incidence of hepatocellular carcinoma in the United States JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199903113401001 DO - 10.1056/NEJM199903113401001 ID - El-Serag1999 ER - TY - JOUR AU - Thomas, M. B. AU - Jaffe, D. AU - Choti, M. M. AU - Belghiti, J. AU - Curley, S. AU - Fong, Y. PY - 2010 DA - 2010// TI - Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2010.28.7805 DO - 10.1200/JCO.2010.28.7805 ID - Thomas2010 ER - TY - JOUR AU - Manns, M. P. AU - McHutchison, J. G. AU - Gordon, S. C. AU - Rustgi, V. K. AU - Shiffman, M. AU - Reindollar, R. PY - 2001 DA - 2001// TI - Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06102-5 DO - 10.1016/S0140-6736(01)06102-5 ID - Manns2001 ER - TY - JOUR AU - Fried, M. W. AU - Shiffman, M. L. AU - Reddy, K. R. AU - Smith, C. AU - Marinos, G. AU - Goncales, F. L. PY - 2002 DA - 2002// TI - Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa020047 DO - 10.1056/NEJMoa020047 ID - Fried2002 ER - TY - JOUR AU - Poynard, T. AU - Colombo, M. AU - Bruix, J. AU - Schiff, E. AU - Terg, R. AU - Flamm, S. PY - 2009 DA - 2009// TI - Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy JO - Gastroenterology VL - 136 UR - https://doi.org/10.1053/j.gastro.2009.01.039 DO - 10.1053/j.gastro.2009.01.039 ID - Poynard2009 ER - TY - JOUR AU - Jensen, D. M. AU - Marcellin, P. AU - Freilich, B. AU - Andreone, P. AU - Di, B. A. AU - Brandao-Mello, C. E. PY - 2009 DA - 2009// TI - Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-8-200904210-00007 DO - 10.7326/0003-4819-150-8-200904210-00007 ID - Jensen2009 ER - TY - JOUR AU - Lawitz, E. AU - Mangia, A. AU - Wyles, D. AU - Rodriguez-Torres, M. AU - Hassanein, T. AU - Gordon, S. C. PY - 2013 DA - 2013// TI - Sofosbuvir for previously untreated chronic hepatitis C infection JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214853 DO - 10.1056/NEJMoa1214853 ID - Lawitz2013 ER - TY - JOUR AU - Lawitz, E. AU - Poordad, F. F. AU - Pang, P. S. AU - Hyland, R. H. AU - Ding, X. AU - Mo, H. PY - 2014 DA - 2014// TI - Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial JO - Lancet VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)62121-2 DO - 10.1016/S0140-6736(13)62121-2 ID - Lawitz2014 ER - TY - JOUR AU - Lawitz, E. AU - Sulkowski, M. S. AU - Ghalib, R. AU - Rodriguez-Torres, M. AU - Younossi, Z. M. AU - Corregidor, A. PY - 2014 DA - 2014// TI - Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)61036-9 DO - 10.1016/S0140-6736(14)61036-9 ID - Lawitz2014 ER - TY - JOUR AU - Jacobson, I. M. AU - Gordon, S. C. AU - Kowdley, K. V. AU - Yoshida, E. M. AU - Rodriguez-Torres, M. AU - Sulkowski, M. S. PY - 2013 DA - 2013// TI - Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1214854 DO - 10.1056/NEJMoa1214854 ID - Jacobson2013 ER - TY - JOUR AU - Kowdley, K. V. AU - Lawitz, E. AU - Crespo, I. AU - Hassanein, T. AU - Davis, M. N. AU - DeMicco, M. PY - 2013 DA - 2013// TI - Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial JO - Lancet VL - 381 UR - https://doi.org/10.1016/S0140-6736(13)60247-0 DO - 10.1016/S0140-6736(13)60247-0 ID - Kowdley2013 ER - TY - JOUR AU - Sulkowski, M. S. AU - Gardiner, D. F. AU - Rodriguez-Torres, M. AU - Reddy, K. R. AU - Hassanein, T. AU - Jacobson, I. PY - 2014 DA - 2014// TI - Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1306218 DO - 10.1056/NEJMoa1306218 ID - Sulkowski2014 ER - TY - JOUR AU - Afdhal, N. AU - Zeuzem, S. AU - Kwo, P. AU - Chojkier, M. AU - Gitlin, N. AU - Puoti, M. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1402454 DO - 10.1056/NEJMoa1402454 ID - Afdhal2014 ER - TY - JOUR AU - Afdhal, N. AU - Reddy, K. R. AU - Nelson, D. R. AU - Lawitz, E. AU - Gordon, S. C. AU - Schiff, E. PY - 2014 DA - 2014// TI - Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection JO - N Engl J Med VL - 370 UR - https://doi.org/10.1056/NEJMoa1316366 DO - 10.1056/NEJMoa1316366 ID - Afdhal2014 ER - TY - JOUR AU - Petta, S. AU - Cabibbo, G. AU - Enea, M. AU - Macaluso, F. S. AU - Plaia, A. AU - Bruno, R. PY - 2014 DA - 2014// TI - Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C JO - Hepatology VL - 59 UR - https://doi.org/10.1002/hep.27010 DO - 10.1002/hep.27010 ID - Petta2014 ER - TY - JOUR AU - Asselah, T. AU - Estrabaud, E. AU - Bieche, I. AU - Lapalus, M. AU - De, M. S. AU - Vidaud, M. PY - 2010 DA - 2010// TI - Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin JO - Liver Int VL - 30 UR - https://doi.org/10.1111/j.1478-3231.2010.02283.x DO - 10.1111/j.1478-3231.2010.02283.x ID - Asselah2010 ER - TY - JOUR AU - Khattab, M. AU - Eslam, M. AU - Sharwae, M. A. AU - Shatat, M. AU - Ali, A. AU - Hamdy, L. PY - 2010 DA - 2010// TI - Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients JO - Am J Gastroenterol VL - 105 UR - https://doi.org/10.1038/ajg.2010.110 DO - 10.1038/ajg.2010.110 ID - Khattab2010 ER - TY - JOUR AU - Ramcharran, D. AU - Wahed, A. S. AU - Conjeevaram, H. S. AU - Evans, R. W. AU - Wang, T. AU - Belle, S. H. PY - 2010 DA - 2010// TI - Associations between serum lipids and hepatitis C antiviral treatment efficacy JO - Hepatology VL - 52 UR - https://doi.org/10.1002/hep.23796 DO - 10.1002/hep.23796 ID - Ramcharran2010 ER - TY - JOUR AU - Amanzada, A. AU - Goralczyk, A. D. AU - Moriconi, F. AU - Thiel, D. H. AU - Ramadori, G. AU - Mihm, S. PY - 2013 DA - 2013// TI - Vitamin D status and serum ferritin concentration in chronic hepatitis C virus type 1 infection JO - J Med Virol VL - 85 UR - https://doi.org/10.1002/jmv.23632 DO - 10.1002/jmv.23632 ID - Amanzada2013 ER - TY - JOUR AU - Amanzada, A. AU - Goralczyk, A. D. AU - Schneider, S. AU - Moriconi, F. AU - Lindhorst, A. AU - Mihm, S. PY - 2012 DA - 2012// TI - High predictability of a sustained virological response (87%) in chronic hepatitis C virus genotype 1 infection treatment by combined IL28B genotype analysis and gamma-glutamyltransferase/alanine aminotransferase ratio: a retrospective single-center study JO - Digestion VL - 86 UR - https://doi.org/10.1159/000339879 DO - 10.1159/000339879 ID - Amanzada2012 ER - TY - JOUR AU - Bibert, S. AU - Roger, T. AU - Calandra, T. AU - Bochud, M. AU - Cerny, A. AU - Semmo, N. PY - 2013 DA - 2013// TI - IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction JO - J Exp Med VL - 210 UR - https://doi.org/10.1084/jem.20130012 DO - 10.1084/jem.20130012 ID - Bibert2013 ER - TY - JOUR AU - Prokunina-Olsson, L. AU - Muchmore, B. AU - Tang, W. AU - Pfeiffer, R. M. AU - Park, H. AU - Dickensheets, H. PY - 2013 DA - 2013// TI - A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus JO - Nat Genet VL - 45 UR - https://doi.org/10.1038/ng.2521 DO - 10.1038/ng.2521 ID - Prokunina-Olsson2013 ER - TY - JOUR AU - Bartenschlager, R. AU - Lohmann, V. PY - 2000 DA - 2000// TI - Replication of the hepatitis C virus JO - Baillieres Best Pract Res Clin Gastroenterol VL - 14 UR - https://doi.org/10.1053/bega.1999.0073 DO - 10.1053/bega.1999.0073 ID - Bartenschlager2000 ER - TY - JOUR AU - Honda, M. AU - Brown, E. A. AU - Lemon, S. M. PY - 1996 DA - 1996// TI - Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA JO - RNA VL - 2 ID - Honda1996 ER - TY - JOUR AU - Takyar, S. S. AU - Gowans, E. J. AU - Lott, W. B. PY - 2002 DA - 2002// TI - Vitamin B12 stalls the 80 S ribosomal complex on the hepatitis C internal ribosome entry site JO - J Mol Biol VL - 319 UR - https://doi.org/10.1016/S0022-2836(02)00300-5 DO - 10.1016/S0022-2836(02)00300-5 ID - Takyar2002 ER - TY - JOUR AU - Lott, W. B. AU - Takyar, S. S. AU - Tuppen, J. AU - Crawford, D. H. AU - Harrison, M. AU - Sloots, T. P. PY - 2001 DA - 2001// TI - Vitamin B12 and hepatitis C: molecular biology and human pathology JO - Proc Natl Acad Sci USA VL - 98 UR - https://doi.org/10.1073/pnas.081072798 DO - 10.1073/pnas.081072798 ID - Lott2001 ER - TY - JOUR AU - Rosenberg, P. AU - Hagen, K. PY - 2011 DA - 2011// TI - Serum B12 levels predict response to treatment with interferon and ribavirin in patients with chronic HCV infection JO - J Viral Hepat VL - 18 UR - https://doi.org/10.1111/j.1365-2893.2010.01288.x DO - 10.1111/j.1365-2893.2010.01288.x ID - Rosenberg2011 ER - TY - JOUR AU - Rocco, A. AU - Compare, D. AU - Coccoli, P. AU - Esposito, C. AU - Di, S. A. AU - Barbato, A. PY - 2013 DA - 2013// TI - Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus JO - Gut VL - 62 UR - https://doi.org/10.1136/gutjnl-2012-302344 DO - 10.1136/gutjnl-2012-302344 ID - Rocco2013 ER - TY - JOUR AU - Mihm, S. AU - Fayyazi, A. AU - Hartmann, H. AU - Ramadori, G. PY - 1997 DA - 1997// TI - Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype JO - Hepatology VL - 25 UR - https://doi.org/10.1002/hep.510250340 DO - 10.1002/hep.510250340 ID - Mihm1997 ER - TY - JOUR AU - Ermens, A. A. AU - Vlasveld, L. T. AU - Lindemans, J. PY - 2003 DA - 2003// TI - Significance of elevated cobalamin (vitamin B12) levels in blood JO - Clin Biochem VL - 36 UR - https://doi.org/10.1016/j.clinbiochem.2003.08.004 DO - 10.1016/j.clinbiochem.2003.08.004 ID - Ermens2003 ER - TY - JOUR AU - Amanzada, A. AU - Schneider, S. AU - Moriconi, F. AU - Lindhorst, A. AU - Suermann, T. AU - Thiel, D. H. PY - 2012 DA - 2012// TI - Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1 JO - J Med Virol VL - 84 UR - https://doi.org/10.1002/jmv.23323 DO - 10.1002/jmv.23323 ID - Amanzada2012 ER - TY - JOUR AU - Forns, X. AU - Lawitz, E. AU - Zeuzem, S. AU - Gane, E. AU - Bronowicki, J. P. AU - Andreone, P. PY - 2014 DA - 2014// TI - Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial JO - Gastroenterology VL - 146 UR - https://doi.org/10.1053/j.gastro.2014.02.051 DO - 10.1053/j.gastro.2014.02.051 ID - Forns2014 ER - TY - JOUR AU - Kau, A. AU - Vermehren, J. AU - Sarrazin, C. PY - 2008 DA - 2008// TI - Treatment predictors of a sustained virologic response in hepatitis B and C JO - J Hepatol VL - 49 UR - https://doi.org/10.1016/j.jhep.2008.07.013 DO - 10.1016/j.jhep.2008.07.013 ID - Kau2008 ER - TY - JOUR AU - Ge, D. AU - Fellay, J. AU - Thompson, A. J. AU - Simon, J. S. AU - Shianna, K. V. AU - Urban, T. J. PY - 2009 DA - 2009// TI - Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance JO - Nature VL - 461 UR - https://doi.org/10.1038/nature08309 DO - 10.1038/nature08309 ID - Ge2009 ER - TY - JOUR AU - Kwo, P. Y. PY - 2012 DA - 2012// TI - Phase III results in Genotype 1 naive patients: predictors of response with boceprevir and telaprevir combined with pegylated interferon and ribavirin JO - Liver Int VL - 32 UR - https://doi.org/10.1111/j.1478-3231.2011.02709.x DO - 10.1111/j.1478-3231.2011.02709.x ID - Kwo2012 ER - TY - JOUR AU - Mihm, S. AU - Monazahian, M. AU - Grethe, S. AU - Fechner, C. AU - Ramadori, G. AU - Thomssen, R. PY - 1999 DA - 1999// TI - Ratio of serum gamma-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-alpha in chronic HCV infection JO - J Med Virol VL - 58 UR - https://doi.org/3.0.CO;2-7 DO - 3.0.CO;2-7 ID - Mihm1999 ER - TY - JOUR AU - Li, D. AU - Lott, W. B. AU - Martyn, J. AU - Haqshenas, G. AU - Gowans, E. J. PY - 2004 DA - 2004// TI - Differential effects on the hepatitis C virus (HCV) internal ribosome entry site by vitamin B12 and the HCV core protein JO - J Virol VL - 78 UR - https://doi.org/10.1128/JVI.78.21.12075-12081.2004 DO - 10.1128/JVI.78.21.12075-12081.2004 ID - Li2004 ER - TY - JOUR AU - Joske, R. A. PY - 1963 DA - 1963// TI - The vitamin B12 content of human liver tissue obtained by aspiration biopsy JO - Gut VL - 4 UR - https://doi.org/10.1136/gut.4.3.231 DO - 10.1136/gut.4.3.231 ID - Joske1963 ER - TY - JOUR AU - Partearroyo, T. AU - Ubeda, N. AU - Montero, A. AU - Achon, M. AU - Varela-Moreiras, G. PY - 2013 DA - 2013// TI - Vitamin B(12) and folic acid imbalance modifies NK cytotoxicity, lymphocytes B and lymphoprolipheration in aged rats JO - Nutrients VL - 5 UR - https://doi.org/10.3390/nu5124836 DO - 10.3390/nu5124836 ID - Partearroyo2013 ER -